+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diabetic Neuropathy Drug"

From
From
From
Diabetic Neuropathy Market Report 2025 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetic Peripheral Neuropathy- Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Peripheral Neuropathy- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Diabetic Neuropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Neuropathy - Pipeline Insight, 2024

  • Drug Pipelines
  • June 2024
  • 80 Pages
  • Global
From
From
From
Diabetic Nephropathy - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Nephropathy - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 80 Pages
  • Global
From
From
Loading Indicator

Diabetic Neuropathy Drug is a type of Central Nervous System (CNS) drug used to treat nerve damage caused by diabetes. It works by blocking the transmission of pain signals from the nerves to the brain. Commonly used drugs include anticonvulsants, antidepressants, and opioids. These drugs can help reduce pain, improve sleep, and improve quality of life. Side effects may include drowsiness, dizziness, and nausea. The Diabetic Neuropathy Drug market is a rapidly growing segment of the CNS drug market. It is driven by the increasing prevalence of diabetes, as well as the need for effective treatments for diabetic neuropathy. The market is expected to continue to grow in the coming years, as new treatments are developed and approved. Some companies in the Diabetic Neuropathy Drug market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more